Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome

Kimber Stanhope

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

There is controversy concerning the role of sugar in the epidemics of obesity and metabolic syndrome. There is less controversy concerning the effects of fructose on components of metabolic syndrome; consumption of fructose has been shown to increase visceral adipose deposition and de novo lipogenesis (DNL), produce dyslipidemia, and decrease insulin sensitivity in older, overweight/obese subjects. This review examines the potential mechanisms of these effects of fructose and considers whether these mechanisms are relevant to the effects of consuming sucrose or high-fructose corn syrup. Evidence demonstrating that the commonly consumed sugars increase visceral adipose deposition, DNL, and insulin insensitivity is limited or inconclusive. Evidence that sugar consumption promotes development of an unfavorable lipid profile is strong and suggests that the upper added sugar consumption limit of 25% of energy or less, suggested in the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans 2010, may merit re-evaluation.

Original languageEnglish (US)
Pages (from-to)329-343
Number of pages15
JournalAnnual Review of Medicine
Volume63
DOIs
StatePublished - 2012

Fingerprint

Fructose
Sugars
Nutrition Policy
Lipogenesis
Obesity
Advisory Committees
Insulin
Dyslipidemias
Sucrose
Insulin Resistance
Lipids

Keywords

  • Fructose
  • Glucose
  • High-fructose corn syrup
  • Insulin resistance
  • Lipid dysregulation
  • Sucrose

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome. / Stanhope, Kimber.

In: Annual Review of Medicine, Vol. 63, 2012, p. 329-343.

Research output: Contribution to journalArticle

@article{3b9c58e7a1984f16afe4dd6b40c1661e,
title = "Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome",
abstract = "There is controversy concerning the role of sugar in the epidemics of obesity and metabolic syndrome. There is less controversy concerning the effects of fructose on components of metabolic syndrome; consumption of fructose has been shown to increase visceral adipose deposition and de novo lipogenesis (DNL), produce dyslipidemia, and decrease insulin sensitivity in older, overweight/obese subjects. This review examines the potential mechanisms of these effects of fructose and considers whether these mechanisms are relevant to the effects of consuming sucrose or high-fructose corn syrup. Evidence demonstrating that the commonly consumed sugars increase visceral adipose deposition, DNL, and insulin insensitivity is limited or inconclusive. Evidence that sugar consumption promotes development of an unfavorable lipid profile is strong and suggests that the upper added sugar consumption limit of 25{\%} of energy or less, suggested in the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans 2010, may merit re-evaluation.",
keywords = "Fructose, Glucose, High-fructose corn syrup, Insulin resistance, Lipid dysregulation, Sucrose",
author = "Kimber Stanhope",
year = "2012",
doi = "10.1146/annurev-med-042010-113026",
language = "English (US)",
volume = "63",
pages = "329--343",
journal = "Annual Review of Medicine",
issn = "0066-4219",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome

AU - Stanhope, Kimber

PY - 2012

Y1 - 2012

N2 - There is controversy concerning the role of sugar in the epidemics of obesity and metabolic syndrome. There is less controversy concerning the effects of fructose on components of metabolic syndrome; consumption of fructose has been shown to increase visceral adipose deposition and de novo lipogenesis (DNL), produce dyslipidemia, and decrease insulin sensitivity in older, overweight/obese subjects. This review examines the potential mechanisms of these effects of fructose and considers whether these mechanisms are relevant to the effects of consuming sucrose or high-fructose corn syrup. Evidence demonstrating that the commonly consumed sugars increase visceral adipose deposition, DNL, and insulin insensitivity is limited or inconclusive. Evidence that sugar consumption promotes development of an unfavorable lipid profile is strong and suggests that the upper added sugar consumption limit of 25% of energy or less, suggested in the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans 2010, may merit re-evaluation.

AB - There is controversy concerning the role of sugar in the epidemics of obesity and metabolic syndrome. There is less controversy concerning the effects of fructose on components of metabolic syndrome; consumption of fructose has been shown to increase visceral adipose deposition and de novo lipogenesis (DNL), produce dyslipidemia, and decrease insulin sensitivity in older, overweight/obese subjects. This review examines the potential mechanisms of these effects of fructose and considers whether these mechanisms are relevant to the effects of consuming sucrose or high-fructose corn syrup. Evidence demonstrating that the commonly consumed sugars increase visceral adipose deposition, DNL, and insulin insensitivity is limited or inconclusive. Evidence that sugar consumption promotes development of an unfavorable lipid profile is strong and suggests that the upper added sugar consumption limit of 25% of energy or less, suggested in the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans 2010, may merit re-evaluation.

KW - Fructose

KW - Glucose

KW - High-fructose corn syrup

KW - Insulin resistance

KW - Lipid dysregulation

KW - Sucrose

UR - http://www.scopus.com/inward/record.url?scp=84855912244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855912244&partnerID=8YFLogxK

U2 - 10.1146/annurev-med-042010-113026

DO - 10.1146/annurev-med-042010-113026

M3 - Article

C2 - 22034869

AN - SCOPUS:84855912244

VL - 63

SP - 329

EP - 343

JO - Annual Review of Medicine

JF - Annual Review of Medicine

SN - 0066-4219

ER -